231 related articles for article (PubMed ID: 17413406)
1. Status of primary tumour surgical margins in squamous head and neck cancer: prognostic implications.
Bradley PJ; MacLennan K; Brakenhoff RH; Leemans CR
Curr Opin Otolaryngol Head Neck Surg; 2007 Apr; 15(2):74-81. PubMed ID: 17413406
[TBL] [Abstract][Full Text] [Related]
2. Mutated p53 as a molecular marker for the diagnosis of head and neck cancer.
van Houten VM; Tabor MP; van den Brekel MW; Kummer JA; Denkers F; Dijkstra J; Leemans R; van der Waal I; Snow GB; Brakenhoff RH
J Pathol; 2002 Dec; 198(4):476-86. PubMed ID: 12434417
[TBL] [Abstract][Full Text] [Related]
3. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck.
Brennan JA; Mao L; Hruban RH; Boyle JO; Eby YJ; Koch WM; Goodman SN; Sidransky D
N Engl J Med; 1995 Feb; 332(7):429-35. PubMed ID: 7619114
[TBL] [Abstract][Full Text] [Related]
4. Critical evaluation of frozen section margins in head and neck cancer resections.
Black C; Marotti J; Zarovnaya E; Paydarfar J
Cancer; 2006 Dec; 107(12):2792-800. PubMed ID: 17120195
[TBL] [Abstract][Full Text] [Related]
5. Molecular diagnosis of surgical margins and local recurrence in head and neck cancer patients: a prospective study.
van Houten VM; Leemans CR; Kummer JA; Dijkstra J; Kuik DJ; van den Brekel MW; Snow GB; Brakenhoff RH
Clin Cancer Res; 2004 Jun; 10(11):3614-20. PubMed ID: 15173067
[TBL] [Abstract][Full Text] [Related]
6. Association between hypermethylated tumor and paired surgical margins in head and neck squamous cell carcinomas.
Martone T; Gillio-Tos A; De Marco L; Fiano V; Maule M; Cavalot A; Garzaro M; Merletti F; Cortesina G
Clin Cancer Res; 2007 Sep; 13(17):5089-94. PubMed ID: 17785562
[TBL] [Abstract][Full Text] [Related]
7. Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications.
Tabor MP; Brakenhoff RH; van Houten VM; Kummer JA; Snel MH; Snijders PJ; Snow GB; Leemans CR; Braakhuis BJ
Clin Cancer Res; 2001 Jun; 7(6):1523-32. PubMed ID: 11410486
[TBL] [Abstract][Full Text] [Related]
8. Genetically altered fields as origin of locally recurrent head and neck cancer: a retrospective study.
Tabor MP; Brakenhoff RH; Ruijter-Schippers HJ; Kummer JA; Leemans CR; Braakhuis BJ
Clin Cancer Res; 2004 Jun; 10(11):3607-13. PubMed ID: 15173066
[TBL] [Abstract][Full Text] [Related]
9. Surgical margin determination in head and neck oncology: current clinical practice. The results of an International American Head and Neck Society Member Survey.
Meier JD; Oliver DA; Varvares MA
Head Neck; 2005 Nov; 27(11):952-8. PubMed ID: 16127669
[TBL] [Abstract][Full Text] [Related]
10. The role of frozen section histological analysis in the treatment of head and neck skin basal and squamous cell carcinomas.
Bogdanov-Berezovsky A; Rosenberg L; Cagniano E; Silberstein E
Isr Med Assoc J; 2008 May; 10(5):344-5. PubMed ID: 18605355
[TBL] [Abstract][Full Text] [Related]
11. The role of genomic instability in the pathogenesis of squamous cell carcinoma of the head and neck.
Wiseman SM; Stoler DL; Anderson GR
Surg Oncol Clin N Am; 2004 Jan; 13(1):1-11. PubMed ID: 15062358
[TBL] [Abstract][Full Text] [Related]
12. Intraoperative molecular margin analysis in head and neck cancer.
Goldenberg D; Harden S; Masayesva BG; Ha P; Benoit N; Westra WH; Koch WM; Sidransky D; Califano JA
Arch Otolaryngol Head Neck Surg; 2004 Jan; 130(1):39-44. PubMed ID: 14732766
[TBL] [Abstract][Full Text] [Related]
13. p53 mutations in deep tissues are more strongly associated with recurrence than mutation-positive mucosal margins.
Huang X; Pateromichelakis S; Hills A; Sherriff M; Lyons A; Langdon J; Odell E; Morgan P; Harrison J; Partridge M
Clin Cancer Res; 2007 Oct; 13(20):6099-106. PubMed ID: 17947474
[TBL] [Abstract][Full Text] [Related]
14. Should there be more molecular staging of head and neck cancer to improve the choice of treatments and thereby improve survival?
Almadori G; Bussu F; Paludetti G
Curr Opin Otolaryngol Head Neck Surg; 2008 Apr; 16(2):117-26. PubMed ID: 18327030
[TBL] [Abstract][Full Text] [Related]
15. Basal cell carcinoma histological clearance margins: an analysis of 1539 conventionally excised tumours. Wider still and deeper?
Griffiths RW; Suvarna SK; Stone J
J Plast Reconstr Aesthet Surg; 2007; 60(1):41-7. PubMed ID: 17126265
[TBL] [Abstract][Full Text] [Related]
16. Current status of biomarkers in head and neck cancer.
Chang SS; Califano J
J Surg Oncol; 2008 Jun; 97(8):640-3. PubMed ID: 18493942
[TBL] [Abstract][Full Text] [Related]
17. A disturbance in the force--mitochondrial mutations in squamous cell carcinoma of the head and neck.
Cohen EE
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4317-9. PubMed ID: 17671110
[No Abstract] [Full Text] [Related]
18. Second field tumors: a new opportunity for cancer prevention?
Braakhuis BJ; Brakenhoff RH; Leemans CR
Oncologist; 2005 Aug; 10(7):493-500. PubMed ID: 16079316
[TBL] [Abstract][Full Text] [Related]
19. Expanding fields of genetically altered cells in head and neck squamous carcinogenesis.
Braakhuis BJ; Leemans CR; Brakenhoff RH
Semin Cancer Biol; 2005 Apr; 15(2):113-20. PubMed ID: 15652456
[TBL] [Abstract][Full Text] [Related]
20. Genetic progression model for head and neck cancer: implications for field cancerization.
Califano J; van der Riet P; Westra W; Nawroz H; Clayman G; Piantadosi S; Corio R; Lee D; Greenberg B; Koch W; Sidransky D
Cancer Res; 1996 Jun; 56(11):2488-92. PubMed ID: 8653682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
